Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 934-938

  Chiu, Yvonne E ^a   Drolet, Beth A ^a   Blei, Francine ^b   Carcao, Manuel ^c   Fangusaro, Jason ^d   Kelly, Michael E ^a   Krol, Alfons ^e   Lofgren, Sabra ^e   Mancini, Anthony J ^d   Metry, Denise W ^f   Recht, Michael ^g   Silverman, Robert A ^h   Tom, Wynnis L ⁱ   Pope, Elena ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Vascular Birthmark Institute of New York   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTHWESTERN UNIVERSITY   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kaposiform hemangioendothlioma; Kasabach Merritt; Propranolol; Treatment; Tufted angioma; Vascular tumor

Indexed keywords

PREDNISOLONE; PROPRANOLOL; VINCRISTINE;

ANGIOMA; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HEMANGIOENDOTHELIOMA; HUMAN; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; THROMBOCYTE COUNT; TREATMENT OUTCOME; TUFTED ANGIOMA; TUMOR GROWTH;

ADRENERGIC BETA-ANTAGONISTS; CHILD, PRESCHOOL; FEMALE; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; KASABACH-MERRITT SYNDROME; MALE; PROPRANOLOL; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 84866169497     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24103     Document Type: Article

References (12)

1. Jones EW, Orkin M. Tufted angioma (angioblastoma). A benign progressive angioma, not to be confused with kaposi's sarcoma or low-grade angiosarcoma. J Am Acad Dermatol 1989; 20: 214-225.
2. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with kasabach-merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993; 17: 321-328.
3. Lyons LL, North PE, Mac-Moune Lai F, et al. Kaposiform hemangioendothelioma: A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004; 28: 559-568.
4. Fernandez Y, Bernabeu-Wittel M, Garcia-Morillo JS. Kaposiform hemangioendothelioma. Eur J Intern Med 2009; 20: 106-113.
5. Herron MD, Coffin CM, Vanderhooft SL. Tufted angiomas: Variability of the clinical morphology. Pediatr Dermatol 2002; 19: 394-401.
6. Enjolras O, Wassef M, Mazoyer E, et al. Infants with kasabach-merritt syndrome do not have "true" hemangiomas. J Pediatr 1997; 130: 631-640.
7. Kelly M. Kasabach-merritt phenomenon. Pediatr Clin North Am 2010; 57: 1085-1089.
8. Hermans DJ, van Beynum IM, van der Vijver RJ, et al. Kaposiform hemangioendothelioma with kasabach-merritt syndrome: A new indication for propranolol treatment. J Pediatr Hematol Oncol 2011; 33: e171-e173.
9. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-merritt phenomenon: A retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002; 24: 459-462.
10. Fahrtash F, McCahon E, Arbuckle S. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine. J Pediatr Hematol Oncol 2010; 32: 506-510.
11. Blatt J, Stavas J, Moats-Staats B, et al. Treatment of childhood kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer 2010; 55: 1396-1398.
12. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.